Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and liothyronine for cognitive symptoms after ECT in depressive mood disorder
IRCT20220515054864N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in affective disorder and major depressive disorder (MDD) comparing Donepezil arm, Liothyronine arm and Levothyroxine control arm (3 arms). Primary endpoint: Eden brook test overall score. Started Jun 2022; status: completed.
02
Drugs
donepezilliothyroninelevothyroxine sodium
03
Conditions
affective disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20220515054864N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220515054864N1.